Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2–3)
- 31 October 2008
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 111 (1), 9-12
- https://doi.org/10.1016/j.ygyno.2008.06.012
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The impact of the distribution of human papillomavirus types and associated high-risk lesions in a colposcopy population for monitoring vaccine efficacy.Archives Of Pathology & Laboratory Medicine, 2008
- Vaccines against Human Papillomaviruses - A Major Breakthrough in Cancer PreventionCentral European Journal of Public Health, 2007
- Prevalence of human papillomavirus infection in the genital tract determined by hybrid capture assayThe Brazilian Journal of Infectious Diseases, 2006
- Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trialThe Lancet, 2006
- Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysisThe Lancet, 2005
- Prevalence and typing of HPV DNA by hybrid capture II in women with ASCUS, ASC-H, LSIL, and AGC on ThinPrep® Pap testsDiagnostic Cytopathology, 2004
- Dynamics of Human Papillomavirus Infection between Biopsy and Excision of Cervical Intraepithelial Neoplasia: Results from the ZYC101a ProtocolThe Journal of Infectious Diseases, 2004
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 2003
- Typage des Papillomavirus humains dans les frottis cervicaux de routine. Résultats sur une série de3 778 patientesGynécologie Obstétrique & Fertilité, 2000